Testing effectiveness (Phase 2)Looking for participantsNCT06063850
What this trial is testing
AMT-260 Gene Therapy Study in Adults With Unilateral Refractory Mesial Temporal Lobe Epilepsy
Who this might be right for
Mesial Temporal Lobe Epilepsy
UniQure Biopharma B.V. 12